Invatec Technology Center GmbH
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
7
Ending by 2030
Aug 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 27, 2027The maintenance fee for Drug eluting balloon for the treatment of stenosis and method of manufacturing the balloon (US 9,168,362) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Pharmaceutical-coated medical products, the production thereof and the use thereof (US 9,220,875) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Jul 14, 2027The maintenance fee for Controlled expansion balloon catheter (US 10,532,189) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Drug-eluting medical device (US 10,596,303) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,220,875 | Pharmaceutical-coated medical products, the production thereof and the use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,974,931 | Pharmaceutical-coated medical products, the production thereof and the use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,870,940 | Endolumenal prosthesis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,029,032 | Drug-eluting medical device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,596,303 | Drug-eluting medical device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,874,770 | Drug-eluting medical device In force · From the USPTO record | In force | From the USPTO record | |
| US 8,608,689 | Pharmaceutical-coated medical products, the production thereof and the use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,168,362 | Drug eluting balloon for the treatment of stenosis and method of manufacturing the balloon In force · From the USPTO record | In force | From the USPTO record | |
| US 10,532,189 | Controlled expansion balloon catheter In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded